Chinese Pharmaceutical Policy Studies

Drug procurement through central tender   //  Pharmaceutical commerce  // Drugs used in community   // Drug pricing and prices   //  Hospital regulations  //
Pharmaceutical industry   // New rural cooperative medical services // Prescription  // Urban employees' basic medical insurance   // Sectors combination

Sectors combination

 

20000221 Guidelines on Urban Medical System Reform

 

Ÿ           implementing cross-industry management within health sector;

Ÿ           establish the sort management system of medical facilities;

Ÿ           establish and improve the medical service system with rational combination of community health services facilities, general hospitals and special hospitals;

Ÿ           strengthen the macro-management of medical resources allocation;

Ÿ           reform prevention and health care system;

Ÿ           implementing separate calculation and management of medical services and drug sales;

Ÿ           regulate the scopes and methods of financial subsidy;

Ÿ           adjusting the prices of medical services to reflect the labour values of health workers;

Ÿ           further adjusting the structure of medical production:

• control pharmaceutical manufacturers’ inclusion and prevent repeated construction;

• establish scientific approval system for new drugs to reduce R&D and management costs and encourage pharmaceutical manufacturers increasing the investment to R&D;

Ÿ           promote medicines distribution system reform:

• promote cross-district and chained distribution;

• regulate the drug procurement behaviour of medical facilities: promote central tender and web techniques;

Ÿ           strengthen legislation auditing and management: cancel medicine market fairs;

Ÿ           adjusting medicine prices: government pricing or government instructive pricing and market pricing;

Ÿ           Strengthen the leadership.

 

20041009 Strengthening Medical and Drug Prices Auditing and Reducing Civilian's Burden of Medical Expenditure

Ÿ           continue to reduce the prices of government pricing medicines;

• reduce the irrational profits in distribution;

• improve production costs investigation and examining system;

• explore the policies on encouraging the production and distribution of essential but cheap medicines with difficult procurement;

• for government pricing drugs, the substitution of other medicines and rational price ratios among different dosages, formulation and categories should be considered;

Ÿ           regulate enterprises’ market pricing behaviours:

• price authorities should strengthen the audit of market pricing behaviours;

• if the prices are too high, price authorities should regulate their behaviors through keeping the public informed with prices information and discouraging;

• make fully use of procurement through bidding and fixed price differential ratio of distribution to reduce mark-ups; where there is no procurement through bidding in place, fixed price differential ratios and profit rates according to law can be implemented;

Ÿ           establish and improve internal price management system in medical facilities: including keeping the public informed of prices and medical expenses invoice system;

Ÿ           strengthen doctors’ prescription management

• establish measures of rational use of drugs for doctors according to clinical STG and clinical principles for drug uses;

• medical facilities should publicize the prescription situation of each department and doctor regularly and apply rational use of drugs as an important basis of evaluation and promotion;

• the names of medicines prescribed have to implement Prescription Management Measures strictly;

• health facilities cannot restrict patients to purchase medicines in other health facilities or pharmacies with prescription;

Ÿ           explore new medical payment methods: if possible, DRG can be impl20041009 Strengthening Medical and Drug Prices Auditing and Reducing Civilian's Burden of Medical Expenditure emented.